Results for “”

Entry Author Date Location
Dems and GOP Senators Unite Versus Big Tech on Data Privacy Bills 06/24/19 San Francisco
Review: Inside the House of Lies at Theranos 06/24/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Four More Through the IPO Door as Life Science Firms Raise $465M 06/20/19 National
With $45M Nurix Deal, Gilead Enters Crowded Protein Degradation Field 06/19/19 San Francisco
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business 06/17/19 San Francisco
Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More 06/14/19 National
Can AI Tools, $76M Lead BlackThorn to Targeted Psych Drugs? 06/13/19 San Francisco
IPO Scorecard: CrowdStrike Gains 70 Percent on First Trading Day 06/12/19 San Francisco
CymaBay Therapeutics Stumbles in NASH Race, Shares Fall 06/11/19 San Francisco
Salesforce to Boost Analytics Suite With $15.7B Deal to Buy Tableau 06/10/19 San Francisco
Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More 06/07/19 National
Grail’s Cook Steps Down, Former Juno Executive Bishop Named CEO 06/06/19 San Francisco
Synapse Banks $33M to Grow its Automated Back Office for Fintechs 06/06/19 San Francisco
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More 06/05/19 National
Apple Touts New Privacy Moves as Antitrust Probes Loom for Big Tech 06/04/19 San Francisco
Study: Gene Edits in CRISPR Babies Could Boost Risk of Earlier Death 06/03/19 National
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
Quantum Computing 101: Brilliant, Google, Microsoft Training Workers 05/31/19 San Francisco
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes 05/30/19 San Francisco
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer? 05/30/19 National
To Catch Early Cancer, and Rivals, Thrive Banks on Hopkins Blood Test 05/30/19 Boston
CrowdStrike IPO: Cybersecurity Firms Defend Themselves, and You 05/29/19 San Francisco
Immunotherapy Is Now Here For Breast Cancer. What Are Its Prospects? 05/29/19 National
The Biotech IPO Queue Grows Longer as Five More Companies File 05/28/19 National
With Sliver of Data, BioMarin to Seek OK for Hemophilia Gene Therapy 05/28/19 San Francisco
Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M 05/24/19 National
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More 05/24/19 National
Nektar Forms New Company Inheris to Take Reins on Pain, CNS Drugs 05/23/19 San Francisco
Ideaya and Bicycle Therapeutics IPOs Raise $110M for Cancer Drug R&D 05/23/19 San Francisco
Page 1 of 95 next page »